Abi Pinchbeck, Editor, Cell & Gene Therapy Insights, speaks to Arindam Mitra, Director, CMC, Leucid Bio, exploring the development of CAR-T therapies for solid tumors, innovations in automated manufacturing, and the need for cost-effective, scalable solutions. They also discuss the complexities of phase-appropriate analytical testing and the evolving role of artificial intelligence (AI) for data analysis in cell and gene therapy manufacturing.
